The plan explicitly states:

Actively seek pioneering policies for biopharmaceuticals, aligning with the growing demand of precision medicine industries such as gene therapy and stem cells. Additionally, proactively advocate for the implementation of pilot programs—like those already in place in Hainan's Boao Lecheng area—within the new development zone. Seek special policies for the application of medical technologies, and strive for national approval to allow pharmaceuticals, medical devices, and cutting-edge healthcare services—those already approved for market in Hong Kong, Macao, developed countries, or regions—to be used at the Bahuang International Biovalley and the Dapeng New District People's Hospital.

Cultivate multi-tiered innovation entities, focusing on gene technology, Stem cell therapy In precision medicine fields such as high-end health and wellness, personalized diagnostics, and treatment, we will strategically strengthen and supplement key links in the industry chain. This includes identifying and nurturing critical gaps and weak points—both upstream and downstream—in the precision medicine value chain, attracting top-tier global projects to drive localization and commercialization. Additionally, we’ll establish a pipeline for cultivating promising startups, fostering a group of emerging enterprises that showcase exceptional technological capabilities and scalable growth across multiple tiers.

Precisely identify investment attraction priorities and intensify efforts to bring in leading enterprises. Strengthen collaboration with municipal-level departments, working together with various industrial sectors in the New Area to establish a targeted investment promotion platform. Focus on areas such as gene sequencing, In fields such as stem cell therapy Precisely define investment attraction strategies by connecting upstream with global bioresearch resources, bringing in high-quality biopharmaceutical manufacturers and smart medical device companies in the midstream, and expanding downstream application scenarios—thereby further enhancing the concentration of precision medicine within the新区’s industrial ecosystem.

Establish a database for nurturing potential enterprises, helping businesses scale up. Focusing on genetic testing, Stem cell therapy In fields such as pharmaceutical manufacturing and smart medical devices, we will establish a national database for nurturing high-tech enterprises, selecting and incubating a group of technology-driven companies that boast strong technical capabilities and innovative strengths. This initiative will provide targeted support to meet businesses' specific needs, helping them ramp up their R&D efforts. Additionally, we’ll create a "Small-to-Scale-Up" nurturing program, precisely connecting with potential "small-to-scale-up" enterprises and assisting them in aligning resources—such as policy support, space allocation, and financing—to ensure smooth growth.

Accelerate the research and development and industrialization of gene therapy drugs, deeply integrating digital technologies with life sciences. Prioritize research in areas such as gene technology, bio-big data, and digital healthcare applications. Leverage the National Gene Bank to build a robust database resource, establishing a competitive edge for specialized R&D centers in gene technology and bioinformatics. Appropriately manage access permissions to attract more internationally renowned companies and laboratories to join the initiative, while advancing fields like genomics and beyond. Stem Cells and Regenerative Medicine , continuing to deepen expertise in fields such as synthetic biology.

Exploring the development of precision medicine tourism, we aim to attract a major health reinsurance group and collaborate with the existing Letu Watson Life Science Technology Center and other relevant institutions to jointly plan and design an international precision medicine tourism hub. This initiative will bring in a range of biomedical technology-driven precision medicine projects, along with innovative institutions, teams, and cutting-edge platforms. Introducing world-class medical aesthetics, cancer treatment, and anti-aging service providers from Europe to establish a comprehensive platform for stem cell regenerative medicine—encompassing integrated development, international collaboration and exchange, talent cultivation in stem cell regenerative medicine, and cutting-edge scientific research.